Bon Natural Life
3 hedge funds and large institutions have $176K invested in Bon Natural Life in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
319% more capital invested
Capital invested by funds: $42K → $176K (+$134K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$208K |
| 2 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$11.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.78K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$36K |
BON Hedge Fund Activity: Q3 2021 in Review
3 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bon Natural Life (BON) for Q3 2021, worth a combined $176K — up 319% from $42K a quarter earlier.
Fund positioning in BON was balanced in Q3 2021: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $208K. The largest seller was UBS Group, exiting entirely with an estimated $36K sold.
- 3 institutional investors held Bon Natural Life (BON) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $176K of Bon Natural Life stock for Q3 2021, up 319% quarter-over-quarter.
- 1 fund opened new Bon Natural Life positions in Q3 2021 and 1 closed out, a net change of 0 holders.
- The largest Bon Natural Life buyer in Q3 2021 was Marshall Wace, an estimated $208K added.
- The largest Bon Natural Life seller in Q3 2021 was UBS Group, an estimated $36K sold.
Based on aggregated 13F filings for Q3 2021.